Homologous Recombination Deficiency Testing in Women With Ovarian Cancer: An Egyptian Multicentre Study.

However, we identified a significant trend for increasing the rate of HRD‐positive across age categories with the highest at age category 40 to < 60 years and lowest at under 40 years (46% vs. 24%, p trend = 0.034) (Figure 1C ).

also in 9,775 other papers